James Herdegen to United States Food and Drug Administration
This is a "connection" page, showing publications James Herdegen has written about United States Food and Drug Administration.
Connection Strength
0.073
-
Short-term outcome in the first 10 morbidly obese adolescent patients in the FDA-approved trial for laparoscopic adjustable gastric banding. J Pediatr Gastroenterol Nutr. 2007 Oct; 45(4):465-73.
Score: 0.073